scPharmaceuticals
在场
是其中之一......
scPharmaceuticals 是一家在股票代码 SCPH (US) 下上市的公司。
涉及scPharmaceuticals的并购和融资。
- scPharmaceuticals 刚刚宣布为 50 筹款数百万美元。 (公布2022十一月22号).
高管
查看带有其 12 名主要高管的组织结构图
scPharmaceuticals 搜索最多的简介
- John Tucker, Director, President and Chief Executive Officer
- Sara Bonstein, Director
- Minnie Baylor-Henry, Director
创建提醒
跟踪 scPharmaceuticals 的高管变动
药店
scPharmaceuticals 拥有 1,835 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
- Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
- Lundbeck has announced the acquisition of Longboard Pharmaceuticals (公布2024十月17号).
药店 行业的其他推荐联系人
消息
scPharmaceuticals 的最新新闻稿
- scPharmaceuticals Provides Business Update | scPharmaceuticals, Inc.
- scPharmaceuticals Hosting Key Opinion Leader Call on FUROSCIX® (furosemide) for subcutaneous administration | scPharmaceuticals, Inc.
- scPharmaceuticals to Participate in Two Upcoming Investor Conferences | scPharmaceuticals, Inc.
- scPharmaceuticals Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update | scPharmaceuticals, Inc.
- scPharmaceuticals Announces FDA Acceptance of FUROSCIX® New Drug Application Resubmission | scPharmaceuticals, Inc.
- scPharmaceuticals Appoints Sara Bonstein to Board of Directors | scPharmaceuticals, Inc.
- scPharmaceuticals Announces FUROSCIX® NDA Resubmission | scPharmaceuticals, Inc.
- scPharmaceuticals Announces New Presentation Time for BMO’s Virtual 2020 Prescriptions for Success Healthcare Conference | scPharmaceuticals, Inc.
- scPharmaceuticals Inc. to Present at Upcoming Investor Conferences | scPharmaceuticals, Inc.
- scPharmaceuticals Announces Pricing of Public Offering of Common Stock | scPharmaceuticals, Inc.
- View more press releases Close
通过电子邮件
